Clinical Impact of a Digital Home-based Falls Prevention Program on Elderly People
1 other identifier
interventional
100
1 country
1
Brief Summary
This study is a single-center, prospective, non-blind, parallel-group, randomized controlled trial with an experimental and a control group with the aim of evaluating the clinical impact of a home-based falls prevention program using a new biofeedback system on community-dwellers older adults with fall risk in comparison with standard of care. The experimental group will perform a 12-week exercise program at home, under remote monitoring from a clinical team, whereas the control group will benefit from standard medical care currently in place at the participating primary care facility. The hypothesis is that the home-based falls prevention program will lead to a lower risk of falling than standard medical care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2018
CompletedFirst Posted
Study publicly available on registry
November 23, 2018
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
December 6, 2024
December 1, 2024
1.3 years
November 20, 2018
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in the 5 Times Sit to Stand Test
The 5 Times Sit to Stand Test is a performance test that measures the strength and the lower limb mobility. It consists of the time it takes to stand up from a chair five consecutive times. A cutoff value of 15 seconds is used to distinguish between individuals with and without risk of recurrent falls
Baseline; week 4; week 8; week 12 and then week 24
Secondary Outcomes (3)
Change in the Timed Up and Go Test score
Baseline; week 4; week 8; week 12 and then week 24
Change in the Berg Balance Scale
Baseline; week 4; week 8; week 12 and then week 24
Change in the Shorts Falls Efficacy Scale-International
Baseline; week 4; week 8; week 12 and then week 24
Study Arms (2)
Experimental
EXPERIMENTALParticipants included in this arm will benefit from a 12-week exercise program using the novel biofeedback rehabilitation device, under remote monitoring from a physical therapist
Standard of Care
PLACEBO COMPARATORPatients included in this arm will benefit from the standard of care currently in place in the Primary Care facility: education on risk factors for falls, medication review, visual and auditory acuity screening.
Interventions
12-week exercise program performed through the device
Education on falls risk factors and how to minimize them
Medication will be reviewed to reduce sedative drugs and minimize interactions
Patients will go through visual and auditory screening as part of their regular care
Eligibility Criteria
You may qualify if:
- Patients aged over 65 years old
- Ability to walk at least 20 meters, unaided or with unilateral support
- Ability to understand motor complex commands
- Mini-Mental State Examination (MMSE) score \> 24 points
- Functional independence for instrumental activities of daily living
- Risk of recurrent falls, defined as 5xSST score \> 15,00 seconds
You may not qualify if:
- Patients residing in nursing homes, daycare units or assisted-living facilities
- Aphasia, dementia or psychiatric comorbidity, significantly interfering with communication or compliance with a home-based exercise program
- Severe visual our hearing, interfering with communication or with compliance to a home-based exercise program
- Cardiac, respiratory or other condition incompatible with at least 30 minutes of light to moderate physical activity
- Osteoarticular conditions (e.g. severe osteoarthrosis), which prevent the patient from complying with a home-based exercise program
- Patients with neurologic conditions (e.g. stroke, multiple sclerosis, Parkinson's disease)
- Other medical complications, which prevent the patient from complying with a home-based exercise program
- Illiteracy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sword Health, SAlead
Study Sites (1)
USF Aldoar
Porto, Portugal
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2018
First Posted
November 23, 2018
Study Start
May 1, 2025
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data will become available upon study publication, for 5 years.
- Access Criteria
- The protocol will be made available through this platform.
Study protocol and study aggregate results (including anonymised individual patient data) will be made available